Aurora Cannabis Unveils CBD Lozenge in Partnership with Vectura Fertin Pharma
Monday, 9 September 2024, 14:43
Introduction to Aurora's CBD Lozenge
Aurora Cannabis Inc. (NASDAQ: ACB) has recently partnered with Vectura Fertin Pharma, Inc. to expand its product line with a CBD lozenge.
Key Highlights of the Partnership
- Innovative Product: The CBD lozenge is designed for wellness improvement.
- Effective Dosage: Each lozenge contains precise amounts of CBD for consistency.
- Retail Availability: The product will be accessible in various retail sales locations across Canada.
Conclusion on Market Impact
The collaboration signifies a pivotal step in the medical cannabis industry, fostering advancements in consumer access to CBD products.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.